Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Aclasta for osteoporosis

  • Comment
The first annual treatment for post-menopausal osteoporosis has been launched in the UK.
The bisphosphonate zoledronic acid 5mg (Aclasta) is given in a 15 minute intravenous infusion, either in outpatients or a GP surgery.

Ann Allsworth, a clinical nurse specialist at the Royal National Orthopaedic Hospital in Middlesex, said, ‘A once yearly intravenous medication for osteoporosis is a good new option for patients. The patients like it and it is very easy to administer.’
  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs